Membranous nephropathy is a common cause of nephrotic syndrome in adults and can be primary or secondary to systemic lupus erythematosus, chronic infection, or drugs. 1 Crescents are rare in primary membranous nephropathy, and suggest another underlying disease process, such as lupus nephritis. However, in some patients with membranous nephropathy and crescents, the crescentic lesion may be due to a distinct, separate disease process. Here we report a case with such findings and discuss possible implications for pathogenesis.
RESULTS

Clinical History
A 59-year-old white male construction worker was admitted with a 2-week history of increasing fatigue and weakness, low-grade fever, night sweats, and increased serum creatinine (2.84 mg/dl).
He also had nausea, decreased appetite, mild sore throat, and increased shortness of breath. He was treated with antibiotics as an outpatient but did not improve, and he presented to the emergency department when his temperature reached 103.8°F (39.9°C). The patient had no history of rash, cough, sinus symptoms, chest pain, gastrointestinal complaints, or gross hematuria. He had longstanding nocturia and frequency but no dysuria. He had taken naproxyn long term twice a day for arthralgias. Hemochromatosis was diagnosed 7 years ago and was treated with phlebotomy. He also had a history of hypothyroidism and cold agglutinins and was treated for strep throat 1 year earlier.
Examination revealed an obese white man (body mass index of 40) with trace lower-extremity edema and no other abnormal findings. Laboratory evaluation 4 months earlier showed normal serum creatinine (0.9 mg/dl), a serum albumin concentration of 3.4 g/dl, urinalysis with 2ϩ protein, one red blood cell, and five white blood cells (WBCs) without casts. On admission, serum sodium was 136 mEq/L, potassium was 4.3 mEq/L, chloride was 107 mEq/L, bicarbonate was 20 mmol/L, blood urea nitrogen was 36 mg/ dl, serum creatinine was 2.84 mg/dl, magnesium was 2.2 mg/dl, phosphorus was 4.6 mg/dl, total bilirubin was 0.7 mg/ dl, amylase was 17 U/L, and lipase was 14 U/L. Urinalysis revealed a specific gravity of 1.026; 3ϩ albumin; large blood with 21 to 50 red blood cells/high-power field; 5 to 10 WBCs/high-power field; no casts, nitrites, leukocyte esterase, or glucose; and a spot protein-to-creatinine ratio of 2.1 with proteinuria of 5.5 g/24 h. Total serum protein was 6.2 g/dl with a monoclonal IgM kappa spike in blood and urine. The WBC count was 8.500/l (80.6% polymorphonuclear leukocytes, 9.8% lymphocytes, 9.3% monocytes), prothrombin time was 17.4 seconds, partial thromboplastin time was 35.3 seconds, hemoglobin was 12.8 g/dl, hematocrit was 37%, platelet count was 168,000/l, iron saturation was 35%, and ferritin was 794 ng/ml. Erythrocyte sedimentation rate was elevated at 99 mm/h. Serologies for hepatitis A, B, C, HIV, and Ehrlichia and titers for anti-nuclear antibody, anti-neutrophil cytoplas-mic antibody, anti-myeloperoxidase antibodies, cryoglobulin, rheumatoid factor, and anti-phospholipid antibodies were negative. Blood and urine cultures and rapid strep test were negative. Complement 3 (C3) was normal (148 mg/dl) and then decreased to 57 mg/dl 3 days later. Complement 4 was low at admission (10 mg/dl) and decreased to Ͻ4 mg/dl.
The chest x-ray was normal. Kidneys were normal size by ultrasound with mild increased parenchymal echogenicity. A renal biopsy was performed.
Kidney Biopsy
The biopsy showed characteristic features of membranous nephropathy with occasional capillary wall subepithelial spikes and frequent holes on Jones silver stain ( Figure 1A ). In addition, 13 of 26 glomeruli showed cellular crescents with segmental necrosis but with no associated mesangial or endocapillary proliferation or glomerular basement membrane (GBM) splitting. Immunofluorescence showed granular capillary loop 3ϩ intensity for IgG, 1ϩ for C3, 0 to trace for C1q, and 2ϩ for kappa and lambda (0 to 3ϩ scale) (Figure 1B ). IgA and IgM were negative. An underlying 1ϩ linear staining of the GBMs could be discerned for IgG, kappa and lambda. Electron microscopy showed numerous subepithelial and occasional intramembranous deposits and complete overlying foot process effacement ( Figure 1C ). Occasional mesangial deposits were present. No subendothelial deposits or reticular aggregates were present. The final diagnosis was membranous nephropathy with superimposed anti-GBM-antibody-mediated glomerulonephritis.
Clinical Follow-Up
An anti-GBM titer was obtained and was positive at 38 AU/ml. The patient was treated with oral cyclophosphamide 150 mg daily and prednisone 50 mg with plasma exchange. Serum creatinine was 1.78 mg/dl at discharge. Three weeks later, the urinary protein-to-creatinine ratio was 2.8. He was treated with angiotensin converting enzyme inhibitor and then switched to irbesartan because of lip swelling. Proteinuria improved to 400 mg after 3 months. Serum creatinine remained stable between 1.7 and 1.9 mg/dl. Repeat anti-GBM antibody was negative. Because of financial constraints, the patient remained on daily oral cyclophosphamide 150 mg for 5 months, then daily cyclophosphamide 100 mg for 3 months, and then azathioprine 100 mg daily with tapering prednisone. At 7 months after diagnosis, creatinine clearance was 74 ml/min and proteinuria was 330 mg/24 h without hematuria.
DISCUSSION
Initially the patient's acute rise in serum creatinine was thought to be due to decreased renal perfusion in the setting of fever, decreased oral intake, and exposure to nonsteroidal anti-inflammatory drugs. However, because of the systemic signs and symptoms, lack of response to fluids, and active urine sediment, a renal biopsy was done. The renal biopsy showed the unusual combination of membranous nephropathy and crescents. When extensive crescents are superimposed on membranous nephropathy, the possibility of a mixed International Society of Nephrology/Renal Pathology Society class V membranous lupus nephritis with superimposed focal or diffuse class III or class IV lupus nephritis with severe activity should be considered. Typically such a combined lupus nephritis lesion would also have associated endocapillary proliferation and concomitant subendothelial deposits, reticular aggregates, and full house staining by immunofluorescence. Some cases of lupus nephritis may have active necrotizing lesions with minimal subendothelial deposits and proliferation. However, in the patient presented here there were no reticular aggregates, staining of immunoglobulins in deposits was limited to IgG, and the patient did not clinically have lupus.
Pauci-immune necrotizing crescentic glomerulonephritis superimposed on membranous nephropathy is exceptionally rare. In contrast, the combination of anti-GBM antibody glomerulonephritis and membranous nephropathy, albeit also rare, is well recognized. Correct diagnosis relies on a combination of renal biopsy findings and serologic testing. Of note, not all patients with anti-GBM antibodies have circulating anti-GBM detected by standard assays. 27 Recognition of linear staining of the GBM in membranous nephropathy can be technically difficult because of the intense granular staining of the immune complex deposits. Linear immunofluorescence staining of the GBM can be seen in settings other than anti-GBM glomerulonephritis, such as diabetic nephropathy. In diabetic nephropathy, the linear accentuation of the GBM with anti-IgG is typically not accompanied by linear C3 staining, although nonspecific C3 staining may be seen. Tubular and Bowman's capsule basement membranes may also show linear accentuation for anti-IgG in diabetic nephropathy, although usually weaker than the GBM. In anti-GBM antibody glomerulonephritis, variable granular or linear C3 staining is present, and the latter can be continuous or discontinuous. If linear C3 is present, this may be helpful to support a diagnosis of anti-GBM-related disease.
In 1958, Drs. Stanton and Tange described nine patients with acute renal failure and pulmonary hemorrhage linked to antibody formation to the GBM and coined the term "Goodpasture syndrome" in recognition of Dr. Ernest Goodpasture's description of a young man who died with pulmonary hemorrhage and renal failure in the 1918 influenza pandemic. 28 Although the patient described by Goodpasture most likely did not have anti-GBM disease in that he had lesions in organs other than lung and kidney, the Goodpasture eponym became associated with the syndrome of alveolar hemorrhage and rapidly progressive glomerulonephritis and Goodpasture disease when this syndrome was specifically due to anti-GBM antibodies.
Membranous nephropathy associated withanti-GBMantibodyglomerulonephritis was first recognized in 1974. 2 We have identified 25 reported cases in addition to the one presented here of either membranous nephropathy followed by anti-GBM glomeru-lonephritis, mostly in middle-aged or older patients (n ϭ 6); anti-GBM glomerulonephritis followed by membranous nephropathy, mostly in younger adults (n ϭ 6); or simultaneous findings of membranous nephropathy and anti-GBM disease (n ϭ 13) ( Table 1) . Primary membranous nephropathy is due to antibodies reacting to planted, endogenous, podocyte-related antigens, recently demonstrated to be the phospholipase A2 receptor in many cases, 29, 30 and an HLA-DQA1 allele on chromosome 6p21 is most closely associated with these antibodies in Caucasians. 31 Anti-GBM glomerulonephritis is caused by antibodies to the ␣3IV and ␣5IV noncollagenous domains of type IV collagen. 28, 32 Recently, this antibody response has been linked to a conformational change in ␣3, ␣4, and ␣5 collagen protomers. 33 The triggering events for such conformational changes to elicit an autoimmune response remain unknown, although T cell escape from thymic deletion may play a role. 34 Whether membranous nephropathy could facilitate such additional autoimmunity, or vice versa, are interesting hypotheses that remain to be proven. Immune complex deposition 13 20/M Hematuria "Cytotoxic drugs," PP Recovery Savige 13 18/F Hematuria PP, steroids, CP Chronic kidney disease Elder 14 20/M Hemoptysis, dyspnea, fever, hematuria Steroids, CP Recovery, proteinuria Keilstein 15 17/M Hemoptysis, hematuria Antibiotics Recovery M, male; F, female; CP, cyclophosphamide; PP, plasmapheresis. Adapted from Troxell et al. 3 and Patel et al. 26 16 19/F Hemoptysis, hematuria Steroids, azathioprine Nephrectomy, dialysis Sharon 17 25/M Hemoptysis, hematuria, edema Steroids, CP, PP Died (pulmonary hemorrhage) Jennette 18 17/M Sore throat, fever, minimal hemoptysis Steroids, CP Recovery Tomaszewski 19 22/F Hemoptysis, hematuria Pettersson 20 20/M Sore throat, fever, lumbar pain, hematuria along the GBM may cause release of damaged GBM antigens into the circulation or unmask cryptic epitopes, which leads to the formation of nephritogenic anti-GBM antibodies. Alternatively, a patient with an initial anti-GBM antibody-mediated renal lesion could have release of GBM antigens into the circulation that then complex with the circulating anti-GBM antibody, leading to glomerular deposition of immune complexes. Anti-GBM antibodies could also form in situ complexes with freed GBM antigens within capillary walls. Given the patient's history of 2ϩ albuminuria on urinalysis and low serum albumin 4 months before admission, it is possible he then had undiagnosed membranous nephropathy that was possibly due to excessive use of nonsteroidal antiinflammatory drugs. Rapid decline of renal function in membranous nephropathy could be due to several causes, including malignant hypertension; renal vein thrombosis; tubulointerstitial nephritis; crescentic glomerulonephritis; and rarely, as in our patient, anti-GBMmediated disease. Progression to endstage renal disease in such patients has usually been rapid; however, the diagnosis has rarely been made early enough to expect aggressive treatment to be successful. 28 Fortunately, the prompt diagnosis by renal biopsy in our patient allowed early initiation of aggressive therapy. Interestingly, our patient has remained in remission with minimal proteinuria, stable serum creatinine, and with minimal side effects from therapy 2 years after presentation. The remission of proteinuria with bland urine sediment and stable creatinine further suggest the possibility that membranous nephropathy and anti-GBM disease could be pathogenically linked in this patient.
DISCLOSURES
None. Figure 1. (A) Prominent GBM with capillary wall subepithelial spikes is characteristic of membranous nephropathy. Segmental necrosis and cellular crescents are shown (Jones silver stain, ϫ400). (B) Characteristic granular capillary wall staining pattern of subepithelial deposits appear in membranous nephropathy with underlying linear GBM pattern (insert) corresponding to anti-GBM antibody (anti-IgG immunofluorescence ϫ400, insert ϫ2000). (C) Numerous subepithelial and scattered intramembranous deposits with surrounding matrix reaction and overlying effacement of foot processes are diagnostic of membranous glomerulopathy. Anti-GBM antibody binding is not visualized by electron microscopy, which is thought to reflect the diffuse distribution of the antigen, ␣3 (IV) collagen, within the GBM (transmission electron microscopy, ϫ3000).
